Sensorion Logo

Sensorion

Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.

ALSEN | PA

Overview

Corporate Details

ISIN(s):
FR0012596468 (+2 more)
LEI:
969500P0W8XJ9CGZDP97
Country:
France
Address:
375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Sensorion is a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to address hearing loss disorders, a significant global unmet medical need. The company's mission is to restore, treat, and prevent inner ear pathologies through a three-pillar strategy. This approach includes developing gene therapies for genetic forms of hearing loss (Restore), creating innovative small molecule therapeutic solutions (Treat), and establishing targeted programs to prevent non-genetic hearing damage (Prevent). Sensorion leverages a unique R&D technology platform to advance its understanding of the pathophysiology and etiology of inner ear diseases, enabling the development of a cutting-edge therapeutic portfolio.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 07:30
Earnings Release
Inside Information / News release on accounts, results
English 253.3 KB
2025-09-17 07:30
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 273.6 KB
2025-09-04 07:30
Regulatory News Service
Inside Information / Other news releases
English 168.5 KB
2025-09-04 07:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 174.1 KB
2025-08-15 07:30
Capital/Financing Update
Inside Information / Other news releases
English 139.2 KB
2025-08-15 07:30
Capital/Financing Update
Informations privilégiées / Autres communiqués
French 140.2 KB
2025-07-29 07:30
Legal Proceedings Report
Inside Information / Other news releases
English 188.2 KB
2025-07-29 07:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 192.0 KB
2025-07-01 07:30
Earnings Release
Inside Information / Other news releases
English 187.9 KB
2025-07-01 07:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 194.8 KB
2025-05-13 07:30
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 133.2 KB
2025-05-13 07:30
Post-Annual General Meeting Information
Inside Information / Other news releases
English 139.4 KB
2025-05-06 07:30
Regulatory News Service
Inside Information / Other news releases
English 180.6 KB
2025-05-06 07:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 176.8 KB
2025-04-25 07:30
Regulatory News Service
Inside Information / Other news releases
English 151.9 KB

Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sensorion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-04-11 N/A Other Other 2,781,914 1,752,605.82 EUR
2024-04-11 N/A Other Other 1,587,301 999,999.63 EUR
2024-02-13 N/A Other Other 16,842,105 9,599,999.85 EUR
2024-02-08 N/A Other Other 12,280,701 6,999,999.57 EUR
2023-08-08 N/A Other Other 46,428,571 12,999,999.88 EUR
2023-08-03 N/A Other Other 25,000,000 7,000,000.00 EUR

Peer Companies

Company Country Ticker View
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.